Petricoin, III; Emanuel F.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Petricoin, III; Emanuel F..The latest application filed is for "a method of determining risk for skin cancer development and skin cancer therapeutic prevention by measuring pd-1/pd-l1 signaling pathway members".

Company Profile

0.10.14

Petricoin, III; Emanuel F. - Manassas VA
Petricoin, III; Emanuel F. - Dunkirk MD
Petricoin, III; Emanuel F. - Gainesville VA US
Petricoin, III; Emanuel F. - Rockville MD

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
A Method Of Determining Risk For Skin Cancer Development And Skin Cancer Therapeutic Prevention By Measuring Pd-1/pd-l1 Signaling Pathway Members App 20220017969 - Curiel; Clara N. ; et al.	2022-01-20
Method And Apparatus For Signal Transduction Pathway Profiling App 20160320401 - Liotta; Lance ; et al.	2016-11-03
Method and apparatus for signal transduction pathway profiling Grant 9,335,328 - Liotta , et al. May 10, 2	2016-05-10
Phosphorylated C-ErbB2 as a superior predictive theranostic marker for the diagnosis and treatment of cancer Grant 9,086,414 - Petricoin, III , et al. July 21, 2	2015-07-21
Method For Detecting And Controlling Cancer App 20150118246 - Petricoin, III; Emanuel F. ; et al.	2015-04-30
Method for detecting and controlling cancer Grant 8,834,873 - Petricoin, III , et al. September 16, 2	2014-09-16
Signal Pathway Alterations And Drug Target Elevations In Primary Metachronous Metastatic Colorectal Cancer Compared To Non-metastatic Disease App 20140030254 - Petricoin, III; Emanuel F. ; et al.	2014-01-30
mTOR pathway theranostic Grant 8,628,931 - Liotta , et al. January 14, 2	2014-01-14
Ex Vivo Therapeutics Screening Of Living Bone Marrow Cells For Multiple Myeloma App 20110207627 - Liotta; Lance A. ; et al.	2011-08-25
Signal Pathway Alterations And Drug Target Elevations In Primary Metachronous Metastatic Colorectal Cancer Compared To Non-metastatic Disease App 20110200597 - Petricoin, III; Emanuel F. ; et al.	2011-08-18
PHOSPHORYLATED C-ErbB2 AS A SUPERIOR PREDICTIVE THERANOSTIC MARKER FOR THE DIAGNOSIS AND TREATMENT OF CANCER App 20110189173 - Petricoin, III; Emanuel F. ; et al.	2011-08-04
Calibrated Rpma Assay App 20100203549 - Petricoin, III; Emanuel F. ; et al.	2010-08-12
Method For Detecting And Controlling Cancer App 20100074895 - Petricoin, III; Emanuel F. ; et al.	2010-03-25
Assay For Metastatic Colorectal Cancer App 20100003247 - Petricoin, III; Emanuel F. ; et al.	2010-01-07
Mtor Pathway Theranostic App 20090148859 - Liotta; Lance A ; et al.	2009-06-11
Quality assurance/quality control for high throughput bioassay process Grant 7,333,896 - Hitt , et al. February 19, 2	2008-02-19
Process for discriminating between biological states based on hidden patterns from biological data Grant 6,925,389 - Hitt , et al. August 2, 2	2005-08-02
Process for discriminating between biological states based on hidden patterns from biological data App 20050043593 - Hitt, Ben A. ; et al.	2005-02-24
Process for discriminating between biological states based on hidden patterns from biological data App 20030004402 - Hitt, Ben A. ; et al.	2003-01-02

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.